BiologicsMD
Pre-clinicalBiologicsMD is developing a series of patent-protected recombinant fusion proteins, each with two functional domains. The first, the Active Domain, provides powerful stimulatory effects at the target receptors and the second, the Binding Domain, localizes the treatment to the point of disease for sustained, targeted, therapeutic exposure with a single, or infrequent, dosing and minimal off-target effects.
Private Company
Total funding raised: $15M
About
BiologicsMD is developing a series of patent-protected recombinant fusion proteins, each with two functional domains. The first, the Active Domain, provides powerful stimulatory effects at the target receptors and the second, the Binding Domain, localizes the treatment to the point of disease for sustained, targeted, therapeutic exposure with a single, or infrequent, dosing and minimal off-target effects.